Abstract
110 consecutively diagnosed breast-cancer patients in all stages were included in a study to evaluate a selective surgical and radiotherapeutical treatment. The surgical treatment was total mastectomy and exploration of the axilla, with lymphnode biopsy and peroperative cytological examination. Axillary dissection was done only when this examination showed metastases. No radiotherapy was given to the axilla in patients with lateral cancers in the absence of metastases, or with limited metastasization (no periglandular growth, no growth in apical nodes). In medial and central cancers, radiotherapy was applied to the parasternal and supraclavicular nodes irrespective of axillary involvement. A staging system with a combined clinical and histopathological classification was used and formed the basis for the selective treatment. The corrected 5-year survival for the whole material was 80%, for those without axillary metastasis (Stage I) 95% and for those with axillary metastasis (Stage II) 68%. Six women were alive with known distant metastases. Of 63 patients without identified axillary metastases at the time of surgery, axillary recurrences occurred in only 3 (5%). It was concluded that patients without axillary metastases can be reliably selected by the peroperative examination used, and that in this group simple mastectomy results in a high disease-free survival. Early diagnosis and a possible beneficial effect of the actual therapeutic programme might both have contributed to the high overall survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Adami, H., Graffman, S., Johansson, H. et al. Survival and recurrences five years after selective treatment for breast carcinoma. Br J Cancer 38, 624–630 (1978). https://doi.org/10.1038/bjc.1978.259
Issue Date:
DOI: https://doi.org/10.1038/bjc.1978.259
This article is cited by
-
Predicting Metastasis in Breast Cancer: Comparing a Decision Tree with Domain Experts
Journal of Medical Systems (2007)
-
Exploring cancer register data to find risk factors for recurrence of breast cancer – application of Canonical Correlation Analysis
BMC Medical Informatics and Decision Making (2005)
-
Diagnosis of axillary lymph node metastases in patients with breast cancer
Breast Cancer Research and Treatment (1996)
-
Intraoperative assessment of axillary lymph node metastases in operable breast cancer
Breast Cancer Research and Treatment (1996)
-
Prognostic implication of estrogen receptor content in breast cancer
Breast Cancer Research and Treatment (1985)